Tachyarrhythmias are common cardiac arrhythmias in newborns and infants. The majority of tachyarrhythmias presenting in infancy depend on the presence of an accessory pathway. In one‐third of patients, tachyarrhythmia never recurs after 1 year of age, but heart failure may develop more easily in neonates and infants depending on the duration, mechanism, and rate of tachycardia.Patients usually present with non‐specific symptoms, such as pallor, difficulty feeding, tachypnea, and excessive sweating. It is diagnosed either during routine physical examination or evaluation for dilated cardiomyopathy. Occasionally, it is detected during follow up for fetal tachycardia.The majority of sustained tachyarrhythmias in children <1 year were treated with a single anti‐arrhythmic drug or a combination of such drugs depending on the spontaneous regression rate. Although it is more risky in those under 1 year than in other age groups, radiofrequency ablation (RFA) or cryoablation can be applied successfully in a limited number of patients refractory to medical treatment. In this study, we report on sustained tachyarrhythmia patients aged <1 year age in terms of presentation, clinical findings, tachyarrhythmia type, and treatment modality.MethodsThe study was conducted retrospectively in a tertiary cardiac center between November 2010 and November 2016, involving all patients <1 year of age who presented with sustained
Pediatrics International – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera